Works matching DE "INSULIN derivatives"

Results: 803
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Effectiveness and Safety of Initiation and Titration of Insulin Glargine 300 U/mL in Insulin-Naive Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetic Drug Treatment in Turkey: The EASE Study.

    Published in:
    Endocrinology Research & Practice, 2024, v. 28, n. 1, p. 4, doi. 10.5152/erp.2024.23311
    By:
    • Çetinarslan, Berrin;
    • Çetinkalp, Şevki;
    • Kaya, Ahmet;
    • Ersoy, Canan;
    • Kebapçı, Nur;
    • Çömlekçi, Abdurrahman;
    • Tütüncü, Neslihan Başçıl;
    • Deyneli, Oğuzhan;
    • Oğuz, Aytekin;
    • İlkova, Hasan;
    • Yılmaz, Temel;
    • Hekimsoy, Zeliha;
    • Ünübol, Mustafa;
    • Balcı, Mustafa Kemal;
    • Atmaca, Ayşegül;
    • Dağdelen, Selçuk;
    • Yetkin, İlhan;
    • Güler, Serdar;
    • Ötünç, Göktürk;
    • Özhan, Leyla
    Publication type:
    Article
    16
    17

    Glycemic control in children with type 1 diabetes: Insulin pump therapy versus multiple daily injections.

    Published in:
    Electronic Journal of General Medicine, 2024, v. 21, n. 2, p. 1, doi. 10.29333/ejgm/14403
    By:
    • Durmanova, Aigul;
    • Slyamova, Gulnur;
    • Rakhimzhanova, Marzhan;
    • Gusmanov, Arnur;
    • Zhakanova, Gulmira;
    • Abduakhassova, Gulmira;
    • Issabayeva, Assel;
    • Nurgaliyeva, Assiya;
    • Alzhaxina, Alina;
    • Umerzakova, Aigerim;
    • Fedoskina, Kristina;
    • Kalzhanova, Marina;
    • Serikbayeva, Makhabbat;
    • Nabiyev, Altay;
    • Gaipov, Abduzhappar
    Publication type:
    Article
    18
    19
    20

    Multivariate analysis of identity of imported technical PCN formulation.

    Published in:
    Journal of Environmental Science & Health. Part A. Toxic/Hazardous Substances & Environmental Engineering, 2008, v. 43, n. 12, p. 1381, doi. 10.1080/10934520802232022
    By:
    • Falandysz, J.;
    • Chudzyński, K.;
    • Takekuma, M.;
    • Yamamoto, T.;
    • Noma, Y.;
    • Hanari, N.;
    • Yamashita, N.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2412, doi. 10.1111/dom.15560
    By:
    • Christofides, Elena A.;
    • Puente, Orlando;
    • Norwood, Paul;
    • Denham, Douglas;
    • Maheshwari, Hiralal;
    • Lillestol, Michael;
    • Hart, Terence;
    • Nakhle, Samer;
    • Chadha, Anurekha;
    • Fitz‐Patrick, David;
    • Sugimoto, Danny;
    • Soufer, Joseph;
    • Young, Douglas;
    • Warren, Mark;
    • Huffman, David;
    • Reed, John;
    • Bays, Harold;
    • Arora, Samir;
    • Rizzardi, Barbara;
    • Tidman, Raymond
    Publication type:
    Article
    42

    Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities‐based post hoc analysis of the OneCare study.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1993, doi. 10.1111/dom.15496
    By:
    • Gomez‐Peralta, Fernando;
    • Chico Ballesteros, Ana;
    • Marco Martínez, Amparo;
    • Pérez Corral, Begoña;
    • Conget Donlo, Ignacio;
    • Fuentealba Melo, Paulina;
    • Zaragozá Arnáez, Fernando;
    • Matabuena Rodríguez, Marcos
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50